Literature DB >> 25260209

Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1.

Gulhan Ertan1, Elcin Zan2, David M Yousem2, Can Ceritoglu3, Aylin Tekes4, Andrea Poretti4, Thierry A G M Huisman4.   

Abstract

Neurofibromatosis bright objects (NBOs) are poorly understood. This article aimed to investigate: 1) differences in fractional anisotropy (FA) between NBOs based in gray matter (GM) and white matter (WM), and 2) the relationship between NBOs and the affected white matter tracts. Fourteen NF1 patients were included in this study. Apparent diffusion coefficient (ADC), FA, radial diffusivity (RD) and eigenvalues were used to compare NBOs and matching contralateral normal-appearing sites (NAS). Diffusion tensor imaging scalars were also compared with age-matched healthy controls. Fiber tractography was performed to assess NBO-induced changes in WM trajectories. ADC values were higher for GM and WM NBOs than for NAS and controls. FA values were lower in GM and WM NBOs compared with controls. In all regions, eigenvalues were higher in NBOs than in NAS and controls. Only three out of 18 NOBs appeared to disrupt WM tracts. ADC, λ2 and RD values of WM NBOs were higher in symptomatic compared to asymptomatic patients. Increased ADC, RD and eigenvalues and decreased FA values in NBOs can be explained by myelin and axonal damage. Increased ADC values and RD in WM NBOs correlated with the presence of symptoms. Tract integrity predominated in our study.

Entities:  

Keywords:  children; diffusion tensor imaging; fiber tractography; neurofibromatosis bright objects; neurofibromatosis type 1

Mesh:

Year:  2014        PMID: 25260209      PMCID: PMC4237104          DOI: 10.15274/NRJ-2014-10055

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  31 in total

1.  In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging.

Authors:  R Xue; P C van Zijl; B J Crain; M Solaiyappan; S Mori
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

Review 2.  Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review.

Authors:  Peter J Basser; Derek K Jones
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

3.  Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture.

Authors:  C Pierpaoli; A Barnett; S Pajevic; R Chen; L R Penix; A Virta; P Basser
Journal:  Neuroimage       Date:  2001-06       Impact factor: 6.556

4.  Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach.

Authors:  Hao Huang; Jiangyang Zhang; Peter C M van Zijl; Susumu Mori
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

5.  Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1.

Authors:  J D Eastwood; D J Fiorella; J F MacFall; D M Delong; J M Provenzale; R S Greenwood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

6.  Cerebral vasculopathy in children with neurofibromatosis type 1.

Authors:  Partha S Ghosh; A David Rothner; Todd M Emch; Neil R Friedman; Manikum Moodley
Journal:  J Child Neurol       Date:  2012-04-24       Impact factor: 1.987

7.  Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water.

Authors:  Sheng-Kwei Song; Shu-Wei Sun; Michael J Ramsbottom; Chen Chang; John Russell; Anne H Cross
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

8.  Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1.

Authors:  Michael A Kraut; Joan P Gerring; Karen L Cooper; Richard E Thompson; Martha B Denckla; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2004-08-30       Impact factor: 2.802

9.  Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1.

Authors:  Shams F Sheikh; Wayne S Kubal; Adam W Anderson; Pradeep Mutalik
Journal:  J Comput Assist Tomogr       Date:  2003 Sep-Oct       Impact factor: 1.826

10.  Unidentified bright objects associated with features of neurofibromatosis 1.

Authors:  Jacek Szudek; J M Friedman
Journal:  Pediatr Neurol       Date:  2002-08       Impact factor: 3.372

View more
  7 in total

Review 1.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

2.  Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analyses.

Authors:  Federico Nemmi; Fabien Cignetti; Christine Assaiante; Stephanie Maziero; Fredrique Audic; Patrice Péran; Yves Chaix
Journal:  Hum Brain Mapp       Date:  2019-05-11       Impact factor: 5.038

3.  Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1.

Authors:  Chang Y Ho; Rachael Deardorff; Stephen F Kralik; John D West; Yu-Chien Wu; Chie-Schin Shih
Journal:  Neuroradiology       Date:  2019-01-25       Impact factor: 2.804

4.  Novel region of interest interrogation technique for diffusion tensor imaging analysis in the canine brain.

Authors:  Jonathan Y Li; Dana M Middleton; Steven Chen; Leonard White; N Matthew Ellinwood; Patricia Dickson; Charles Vite; Allison Bradbury; James M Provenzale
Journal:  Neuroradiol J       Date:  2017-06-19

5.  Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.

Authors:  Peter de Blank; Jeffrey I Berman; Marisa Prelack; John R Sollee; Adam Lane; Amy T Waldman; Michael J Fisher
Journal:  Neurooncol Adv       Date:  2020-06-25

6.  Assessment of Auditory Pathways Using Diffusion Tensor Imaging in Patients with Neurofibromatosis Type 1.

Authors:  Sedat Meydan; Sinem Aydin; Hafize Otcu; Serkan Kitis; Alpay Alkan
Journal:  Curr Med Imaging Rev       Date:  2019

7.  Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).

Authors:  Stavros Stivaros; Shruti Garg; Jonathan Green; Maria Tziraki; Ying Cai; Owen Thomas; Joseph Mellor; Andrew A Morris; Carly Jim; Karolina Szumanska-Ryt; Laura M Parkes; Hamied A Haroon; Daniela Montaldi; Nicholas Webb; John Keane; Francisco X Castellanos; Alcino J Silva; Sue Huson; Stephen Williams; D Gareth Evans; Richard Emsley
Journal:  Mol Autism       Date:  2018-02-22       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.